Encompass Health Co. (NYSE:EHC) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA trimmed its position in shares of Encompass Health Co. (NYSE:EHC) by 24.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,111,144 shares of the company’s stock after selling 350,292 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Encompass Health were worth $107,381,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of EHC. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Encompass Health in the 3rd quarter valued at about $1,778,000. Commerce Bank lifted its position in Encompass Health by 2.6% during the third quarter. Commerce Bank now owns 7,835 shares of the company’s stock worth $757,000 after buying an additional 200 shares in the last quarter. Segall Bryant & Hamill LLC grew its holdings in Encompass Health by 12.6% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 160,137 shares of the company’s stock valued at $15,476,000 after buying an additional 17,902 shares in the last quarter. Avior Wealth Management LLC acquired a new stake in shares of Encompass Health in the 3rd quarter worth $40,000. Finally, PNC Financial Services Group Inc. raised its holdings in shares of Encompass Health by 14.7% during the 3rd quarter. PNC Financial Services Group Inc. now owns 44,017 shares of the company’s stock worth $4,254,000 after acquiring an additional 5,647 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

EHC has been the topic of several recent analyst reports. Barclays boosted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Stephens reiterated an “overweight” rating and issued a $105.00 price objective on shares of Encompass Health in a research report on Tuesday, August 6th. UBS Group lifted their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. KeyCorp increased their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, Truist Financial restated a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $107.11.

Encompass Health Trading Up 1.7 %

Shares of EHC stock opened at $101.12 on Friday. Encompass Health Co. has a fifty-two week low of $63.78 and a fifty-two week high of $104.55. The company has a 50 day moving average price of $97.11 and a 200 day moving average price of $90.84. The stock has a market capitalization of $10.19 billion, a P/E ratio of 24.43, a price-to-earnings-growth ratio of 1.32 and a beta of 0.88. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The company’s revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.86 earnings per share. Equities research analysts predict that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s payout ratio is presently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.